SPRINT and BP targets of anthypertensive treatment
The results of the Systolic Blood Pressure Intervention Trial (SPRINT) have been recently published (New England Journal of Medicine, November 9, 2015).
This was a large trial including 9361 participants with Systolic Blood Pressure (SBP) ≥130 mmHg and high cardiovascular risk but no diabetes or previous stroke. They were treated to a SBP target <120 mmHg (intensive treatment) or to a target <140 mmHg (standard treatment).
The Monthly ESH Guide Through Publications.
On behalf of the ESH it is my pleasure to introduce the ESH Newsletter.
This monthly collection will feature concise summaries of recently published articles dedicated to the most current research on hypertension and related diseases.
The April Newsletter is now available.
In 2015 the ESH Excellence Centres celebrated 10 year of excellence in hypertension and cardiovascular prevention. The rationale for the ESH Excellence Centres was created and further elaborated at the ESH Educational Committee meeting in Italy in July 2005. The European Society of Hypertension (ESH) is making continuous efforts to manage the burden of hypertension in Europe by stimulating scientific exchange related to knowledge about hypertension, and supporting and building organizations committed to work for the control of hypertension.
Join a network of over 1300 hypertension professionals dedicated to scientific research and knowledge and to improving hypertension prevention, treatment and control.
– Eligibility to apply for ESH Hypertension Specialist status
– Eligibility to serve in a leadership capacity in an ESH Excellence Center
– Reduced Member registration fee for the ESH Annual Meeting
– Subscription to the Journal of Hypertension